Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DTN-CKD secondary analysis of dotinurad effects on eGFR and related parameters
jRCT1060260043Active, not recruiting
- Sponsor
- Mochida Pharmaceutical Co., Ltd.
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of dotinurad in hyperuricemia, sponsored by Mochida Pharmaceutical Co., Ltd. Primary endpoints: eGFR slope (change/year), Percent change in eGFR (eGFR change rate) and 1 more. Started Jul 2026; status: active, not recruiting.
02
Drugs
dotinurad
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on jRCT1060260043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1060260043.